ClinicalTrials.Veeva

Menu

Salivary Replication of BK Virus in Post-kidney Transplant (BKSAL)

C

Centre Hospitalier Universitaire, Amiens

Status

Not yet enrolling

Conditions

Nephropathy
Kidney Transplantation
BK Virus
DNAemia
Salivary Replication

Treatments

Biological: Salivary self-collection

Study type

Interventional

Funder types

Other

Identifiers

NCT07256470
PI2024_843_0093

Details and patient eligibility

About

BK virus infection in kidney transplantation can compromise graft function. Current data suggest that BK virus nephropathy results not only from transmission of virus from the donor but also from reactivation of latent virus in the recipient. However, no study has investigated the possibility of respiratory transmission. This study would provide a better understanding of the pathophysiology of BK virus infection in kidney transplant recipients. The investigators would study viral replication of BK virus in saliva, urine and blood of patients who received a kidney transplant at the Amiens University Hospital. For this, the investigators will collect salivary self-collection on the day of the kidney transplant then at 1, 3, 6, 9 and 12 months as well as a urine and blood sample. The investigators will measure BK viral load in these three samples at different times.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • kidney transplant recipients
  • age ≥ 18 years

Exclusion criteria

  • age < 18 years
  • absence of consent

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Ophélie Fourdinier, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems